Tag: cardiovascular outcomes

Night-Time Antihypertensive Dosing: A Personalized Strategy, Not a Universal Recommendation

Announcing a new article publication for Cardiovascular Innovations and Applications which challenges the idea that taking blood pressure medication at bedtime is beneficial for everyone.

In “Night-Time Antihypertensive Dosing: A Personalized Strategy, Not a Universal Recommendation,” researchers Nurul Nabilah Rohaimin and Rajan Rajabalaya from Universiti Brunei Darussalam examine clinical evidence showing that bedtime dosing may improve night-time blood pressure control but does not consistently reduce cardiovascular events.

(more…)

Loading

Continuous Positive Airway Pressure Therapy and Long-Term Outcomes in Patients with Coronary Artery Disease and Obstructive Sleep Apnea: A Meta-Analysis of Randomized Trials

Continuous Positive Airway Pressure Therapy and Long-Term Outcomes in Patients with Coronary Artery Disease and Obstructive Sleep Apnea: A Meta-Analysis of Randomized TrialsAnnouncing a new article publication for Cardiovascular Innovations and Applications journal. Obstructive sleep apnea (OSA) is highly common in patients with coronary artery disease (CAD) and it is a strong predictor of subsequent cardiovascular events. However, whether treatment with continuous positive airway pressure (CPAP) can decrease this risk remains controversial.

PubMed, EMBASE, the Cochrane Library, and ClinicalTrials.gov were systematically searched to identify randomized clinical trials reporting cardiovascular events from database inception to February 12, 2022.

(more…)

Loading